These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6839295)

  • 1. T-antigen does not induce cell mediated immunity in patients with breast cancer.
    Howard DR
    Cancer; 1983 Jun; 51(11):2053-6. PubMed ID: 6839295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic responsiveness of patients with cancer: relationship to tumor type, stage and prognosis.
    Humphrey LJ; Humphrey MA; Singla O; Volenec FJ
    Ann Surg; 1981 May; 193(5):574-8. PubMed ID: 7235762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum blocking factors on leucocyte adherence inhibition and PHA lymphocyte blastogenesis in breast cancer patients.
    Fujisawa T; Yonemoto RH; Waldman SR
    Jpn J Surg; 1981; 11(6):406-12. PubMed ID: 6799680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses in the treatment of advanced carcinoma of the breast. Effects of adrenalectomy.
    Yonemoto RH; Schick P; Albano W; Fujisawa T; Waldman SH
    Arch Surg; 1977 Aug; 112(8):991-6. PubMed ID: 327980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma-associated cytostructural antigenic alterations: detection by lectin binding.
    Howard DR; Ferguson P; Batsakis JG
    Cancer; 1981 Jun; 47(12):2872-7. PubMed ID: 6167345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lymphocyte immunity in breast cancer patients.
    Head JF; Elliott RL; McCoy JL
    Breast Cancer Res Treat; 1993; 26(1):77-88. PubMed ID: 8400326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human carcinoma-associated precursor antigens of the NM blood group system.
    Springer GF; Desai PR; Murthy MS; Scanlon EF
    J Surg Oncol; 1979; 11(2):95-106. PubMed ID: 220469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.
    Gückel B; Rentzsch C; Nastke MD; Marmé A; Gruber I; Stevanović S; Kayser S; Wallwiener D
    J Cancer Res Clin Oncol; 2006 Apr; 132(4):265-74. PubMed ID: 16374613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytostructural localization of a tumor-associated antigen.
    Howard DR; Batsakis JG
    Science; 1980 Oct; 210(4466):201-3. PubMed ID: 6997995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen.
    Springer GF; Murthy MS; Desai PR; Scanlon EF
    Cancer; 1980 Jun; 45(12):2949-54. PubMed ID: 6248184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.
    Nagorsen D; Scheibenbogen C; Schaller G; Leigh B; Schmittel A; Letsch A; Thiel E; Keilholz U
    Int J Cancer; 2003 Jun; 105(2):221-5. PubMed ID: 12673683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte subsets and response of breast cancer and benign mammary disease to PHA].
    Nakao S; Hayashida K; Hasegawa H; Ishii T; Eida K; Noguchi K
    Gan No Rinsho; 1987 Oct; 33(12):1453-8. PubMed ID: 3500331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them.
    Springer GF; Desai PR; Scanlon EF
    Cancer; 1976 Jan; 37(1):169-76. PubMed ID: 55297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiestrogen and progestin on immune functions in breast cancer patients.
    Scambia G; Panici PB; Maccio A; Castelli P; Serri F; Mantovani G; Massidda B; Iacobelli S; Del Giacco S; Mancuso S
    Cancer; 1988 Jun; 61(11):2214-8. PubMed ID: 2966668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.